| Lipid peroxidation as a hallmark of severity in COVID-19 patients M Martín-Fernández, R Aller, M Heredia-Rodríguez, E Gómez-Sánchez, ... Redox Biology 48, 102181, 2021 | 63 | 2021 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 54 | 2023 |
| Novel genes and sex differences in COVID-19 severity R Cruz, S Diz-de Almeida, M López de Heredia, I Quintela, FC Ceballos, ... Human Molecular Genetics 31 (22), 3789-3806, 2022 | 50 | 2022 |
| Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients J Trigo, D García-Azorín, Á Sierra-Mencía, Á Tamayo-Velasco, ... The journal of headache and pain 22 (1), 51, 2021 | 48 | 2021 |
| HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients A Tamayo-Velasco, P Martinez-Paz, MJ Penarrubia-Ponce, I De la Fuente, ... Journal of clinical medicine 10 (9), 2017, 2021 | 46 | 2021 |
| Nosocomial vs. community-acquired infective endocarditis in Spain: location, trends, clinical presentation, etiology, and survival in the 21st century C Ortega-Loubon, MF Muñoz-Moreno, IA García, FJ Álvarez, ... Journal of clinical medicine 8 (10), 1755, 2019 | 32 | 2019 |
| Endothelial dysfunction and neutrophil degranulation as central events in sepsis physiopathology M Martín-Fernández, Á Tamayo-Velasco, R Aller, H Gonzalo-Benito, ... International journal of molecular sciences 22 (12), 6272, 2021 | 29 | 2021 |
| Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression P Martínez-Paz, M Aragón-Camino, E Gómez-Sánchez, M Lorenzo-López, ... Journal of Infection 83 (2), 147-155, 2021 | 23 | 2021 |
| Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection Á Tamayo-Velasco, MJ Peñarrubia-Ponce, FJ Álvarez, H Gonzalo-Benito, ... Journal of personalized medicine 11 (7), 681, 2021 | 19 | 2021 |
| ABO blood system and COVID-19 susceptibility: anti-A and anti-B antibodies are the key points Á Tamayo-Velasco, MJ Peñarrubia-Ponce, FJ Álvarez, I de la Fuente, ... Frontiers in Medicine 9, 882477, 2022 | 18 | 2022 |
| Genetic susceptibility to acute kidney injury C Ortega-Loubon, P Martínez-Paz, E García-Morán, Á Tamayo-Velasco, ... Journal of Clinical Medicine 10 (14), 3039, 2021 | 18 | 2021 |
| Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality M Martín-Fernández, M Heredia-Rodríguez, I González-Jiménez, ... Critical Care 26, 1-9, 2022 | 17 | 2022 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 14 | 2023 |
| Can the cytokine profile according to ABO blood groups be related to worse outcome in COVID-19 patients? yes, they can A Tamayo-Velasco, MJ Penarrubia Ponce, FJ Álvarez, H Gonzalo-Benito, ... Frontiers in immunology 12, 726283, 2021 | 13 | 2021 |
| Gene expression patterns distinguish mortality risk in patients with postsurgical shock P Martínez-Paz, M Aragón-Camino, E Gómez-Sánchez, M Lorenzo-López, ... Journal of Clinical Medicine 9 (5), 1276, 2020 | 11 | 2020 |
| Dyslipidemia and inflammation as hallmarks of oxidative stress in COVID-19: a follow-up study Á Aparisi, M Martín-Fernández, C Ybarra-Falcón, JF Gil, ... International Journal of Molecular Sciences 23 (23), 15350, 2022 | 10 | 2022 |
| Predictive modeling of poor outcome in severe COVID-19: a single-center observational study based on clinical, cytokine and laboratory profiles Ó Gorgojo-Galindo, M Martín-Fernández, MJ Peñarrubia-Ponce, ... Journal of Clinical Medicine 10 (22), 5431, 2021 | 9 | 2021 |
| Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients L Sanchez-de Prada, Ó Gorgojo-Galindo, I Fierro, AM Martínez-García, ... Frontiers in immunology 13, 946730, 2022 | 8 | 2022 |
| HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID‐19 P Castro‐Santos, A Rojas‐Martinez, JA Riancho, P Lapunzina, C Flores, ... HLA 102 (6), 731-739, 2023 | 7 | 2023 |
| Immune checkpoint inhibitors in non-small cell lung cancer: From current perspectives to future treatments—A systematic review A Olivares-Hernández, EG Del Portillo, Á Tamayo-Velasco, ... Annals of Translational Medicine 11 (10), 2023 | 7 | 2023 |
